TATA HEALTH (01255) announced its annual results for the year ended December 31, 2025. The group reported revenue of HK$99.799 million, a decrease of 23.04% compared to the previous year. Profit attributable to owners of the company for the year was HK$13.35 million, a significant turnaround from a loss of HK$68.338 million in the same period last year. Basic earnings per share were HK$0.05.

According to the announcement, the footwear business contributed 100% of the group's total revenue for the year. Revenue from the group's footwear business during the year was approximately HK$99.8 million, representing a decrease of 23.1% year-on-year. The decline in revenue from the footwear business was primarily attributed to weak consumer sentiment caused by ongoing economic uncertainty, which created a challenging environment for the Hong Kong retail sector during the year.